Form 4: Palisade Bio Director Acquires Shares Through Vesting of Restricted Stock Units

Palisade Bio director Donald Allen Williams acquired 388 shares of common stock through the vesting of restricted stock units.

Summary

• Donald Allen Williams, a director at Palisade Bio, acquired 388 shares of common stock on November 21, 2024.
• These shares were obtained through the vesting of restricted stock units that were granted on November 21, 2023.
• The transaction was reported on November 22, 2024.
• Following the transaction, Mr. Williams directly owns 728 shares of common stock.
• He also indirectly owns 3,000 shares through his defined benefit plan.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation. It is neither particularly positive nor negative, but indicates standard corporate governance practices.

Positives

• The vesting of restricted stock units aligns the director's interests with the company's performance.
• The acquisition of shares increases the director's stake in the company.

Industry Context

This is a routine disclosure of a director's stock transaction, which is common in publicly traded companies. It reflects standard compensation practices using equity-based awards.

Comparison to Industry Standards

• The vesting of restricted stock units is a common practice for compensating directors and executives in publicly traded companies.
• Many companies use similar equity-based compensation plans to align the interests of management with shareholders.
• The specific number of shares and vesting schedule would be unique to Palisade Bio's compensation plan.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Palisade Bio, Director, Donald Allen Williams, Stock Acquisition, Restricted Stock Units, Vesting, Share Ownership, SEC Form 4